Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
about
COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancerNF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationRole of hypoxia and vascular endothelial growth factors in lymphangiogenesisIn vitro comparative models for canine and human breast cancersE-cadherin's dark side: possible role in tumor progressionDevelopmental therapeutics for inflammatory breast cancer: Biology and translational directionsIn vivo lymphatic imaging of a human inflammatory breast cancer model.A stromal gene signature associated with inflammatory breast cancer.Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cellsMarkers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherinArray-based DNA methylation profiling for breast cancer subtype discrimination.Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.Lymphangiogenesis and lymphatic metastasis in breast cancer.Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.Therapeutic angiogenesis and vasculogenesis for tissue regeneration.Analysis of stranded information using an automated procedure for strand specific RNA sequencingBreast carcinomatous tumoral emboli can result from encircling lymphovasculogenesis rather than lymphovascular invasion.The role of cytokines in breast cancer development and progressionInternational expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentCirculating tumor cells in newly diagnosed inflammatory breast cancer.Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients.Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancerChildhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer.The dynamic roles of angiopoietins in tumor angiogenesis.A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.Lymphangiogenesis and lymph node metastasis in breast cancerDistinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis.First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.Role of lymphangiogenesis in epithelial ovarian cancer.Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicatorHyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant ChemotherapyThe lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype.Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeLoss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.
P2860
Q24651871-D34C16CA-984E-4F7C-863F-C4D1C577B866Q24653076-80A715F2-E375-4508-93B6-04DB4F17CC40Q26745683-91A1E09A-067B-4C7D-B449-0C628C5CDDFBQ26752714-A541B5B1-4FC3-4BA5-8F2D-5EFD0DE2673BQ26865483-0D3EA847-E7CB-429D-B469-DB8B5A28B7C2Q28075322-11FCD2C5-ED2B-4EB6-A4C0-C96133059A9BQ30596741-96C40109-89CB-482B-8E82-FDC010D9DE14Q30838525-5510A9A7-E320-48FB-9887-8B7A09226298Q31138996-214406DB-4B95-427B-928E-BAA19E54F698Q33317058-7F104934-D0EA-4606-885F-53E5C1C27360Q33689442-F1CECCBC-FD10-447A-9517-A613C158BDB8Q33802774-3C49B385-9EE2-4213-AE36-CEE932ECF11DQ33816245-203BA9E0-C39A-4803-9A5C-DE830A5DD5AEQ33870504-D2453C2D-0E72-4673-8485-74CBCBE57E32Q33903965-32F28EFA-BC91-4BE1-8704-4440E2C730D8Q33940058-1A95B5BA-58EC-4841-A233-D07C0C16B7FFQ34096844-837829B4-8C3C-4B31-B96F-70BB87D6903AQ34251088-7CB404F1-8B70-4F5B-8AD9-FBA12276B93BQ34343963-2EA6C705-A619-4C64-B9AA-F5985D72FFFCQ34404695-743D7B4D-F87F-4FE3-9BB1-388F7F07C6B4Q34584442-73062979-CEDC-479A-8C90-F315BC906EFDQ34684041-4F37C0C9-7116-4FF4-8056-57435360D246Q34920381-0B624172-44BC-476F-BCA0-214E9E0238A0Q35017523-D27363D3-9F0D-474D-B9F9-8F9D474A05FDQ35052773-A539C36C-6C5A-45B3-8F5E-5BAC3315DE8CQ35217289-3454989D-7705-4E5B-9B94-5A991CCC7996Q35572495-B8894FEC-00AC-4876-A228-010928F11053Q35771435-B7CC67DD-1657-4D63-99EA-59C63EEB076DQ36381383-983F30DE-A0C1-4C9D-B15C-C3831C1D86B5Q36429528-29BC562D-75EC-443F-9F53-0663EF7C68BCQ36514752-B6D95503-5A69-4824-982D-DD826D0EC8F5Q36515990-4982A66D-CDA6-4FFC-8CC8-2CDDAB6CCF3CQ36611440-385A8083-4E76-4031-A927-38974D8490EDQ36612618-2DA03C66-F95C-45EA-9B82-247D6D62E17DQ36614325-2C080DB1-51C4-44ED-B133-E8A4A2291D2AQ36642949-EAD1B3DA-3330-450D-97F0-2B9882EE6537Q36693275-26F3F120-41C6-4FEA-87D7-0DF341D28F37Q36778291-0C2E7F83-E285-4311-8BE1-C0101BBD55FBQ36977572-DA26A75D-5A02-486E-9203-FAE39D9C4A0CQ37189474-ED873DB2-857E-452F-ADB1-621231761F2C
P2860
Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Increased angiogenesis and lym ...... ene expression quantification.
@en
Increased angiogenesis and lym ...... ene expression quantification.
@nl
type
label
Increased angiogenesis and lym ...... ene expression quantification.
@en
Increased angiogenesis and lym ...... ene expression quantification.
@nl
prefLabel
Increased angiogenesis and lym ...... ene expression quantification.
@en
Increased angiogenesis and lym ...... ene expression quantification.
@nl
P2093
P50
P1476
Increased angiogenesis and lym ...... gene expression quantification
@en
P2093
Cecile G Colpaert
Eric A Van Marck
Gert G Van den Eynden
Helen Turley
Ilse Van der Auwera
Luc Y Dirix
Peter B Vermeulen
Peter van Dam
Steven J Van Laere
P304
P356
10.1158/1078-0432.CCR-04-0063
P407
P577
2004-12-01T00:00:00Z